-
Je něco špatně v tomto záznamu ?
PPI Long Term Use: Risk of Neurological Adverse Events
M. Novotny, B. Klimova, M. Valis,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, přehledy
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
PubMed
30671013
DOI
10.3389/fneur.2018.01142
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The purpose of this review study is to reveal a potential threat of one type of such widely used and freely distributed drugs, which are proton pump inhibitors that might be the cause of the onset of both dementia and depression. The authors performed a literature review of available studies on the research topic describing the adverse effect of proton pum inhibitors (PPIs) (omeprazole, esomeprazole, lansoprazole, dexlansoprazole, rabeprazole, pantoprazole, dexrabeprazole, ilaprazole). For a long time, PPIs were considered to be completely safe drug substances for both short and long-term use. In recent years, there have been a few contradictory studis of absolute safety, especially in patients, who have long been using PPIs. At this time when depression and dementia are rising in the population, this is a very worrying fact that needs to be highlighted, and which needs to be carefully studied and evaluated, ideally trying to prevent it. The findings of most research studies described in this review indicate that there is a direct association between the onset of dementia and depression on one side and the long-term use of PPIs on the other.
Biomedical Research Centrum University Hospital Hradec Králové Hradec Králové Czechia
Department of Neurology University Hospital Hradec Kralove Hradec Králové Czechia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19013453
- 003
- CZ-PrNML
- 005
- 20210316131104.0
- 007
- ta
- 008
- 190405s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fneur.2018.01142 $2 doi
- 035 __
- $a (PubMed)30671013
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Novotny, Michal $u Biomedical Research Centrum, University Hospital Hradec Králové, Hradec Králové, Czechia.
- 245 10
- $a PPI Long Term Use: Risk of Neurological Adverse Events / $c M. Novotny, B. Klimova, M. Valis,
- 520 9_
- $a The purpose of this review study is to reveal a potential threat of one type of such widely used and freely distributed drugs, which are proton pump inhibitors that might be the cause of the onset of both dementia and depression. The authors performed a literature review of available studies on the research topic describing the adverse effect of proton pum inhibitors (PPIs) (omeprazole, esomeprazole, lansoprazole, dexlansoprazole, rabeprazole, pantoprazole, dexrabeprazole, ilaprazole). For a long time, PPIs were considered to be completely safe drug substances for both short and long-term use. In recent years, there have been a few contradictory studis of absolute safety, especially in patients, who have long been using PPIs. At this time when depression and dementia are rising in the population, this is a very worrying fact that needs to be highlighted, and which needs to be carefully studied and evaluated, ideally trying to prevent it. The findings of most research studies described in this review indicate that there is a direct association between the onset of dementia and depression on one side and the long-term use of PPIs on the other.
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Klimova, Blanka $u Department of Neurology, University Hospital Hradec Kralove, Hradec Králové, Czechia.
- 700 1_
- $a Valis, Martin $u Department of Neurology, University Hospital Hradec Kralove, Hradec Králové, Czechia.
- 773 0_
- $w MED00174552 $t Frontiers in neurology $x 1664-2295 $g Roč. 9, č. - (2019), s. 1142
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30671013 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20210316131101 $b ABA008
- 999 __
- $a ind $b bmc $g 1392763 $s 1051758
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 9 $c - $d 1142 $e 2018 $i 1664-2295 $m Frontiers in neurology $n Front. neurol. $x MED00174552
- LZP __
- $a Pubmed-20190405